OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 18 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,446,000 | -22.9% | 16,072,000 | 0.0% | 0.13% | -25.3% |
| Q2 2016 | $5,766,000 | -13.0% | 16,072,000 | 0.0% | 0.17% | -14.7% |
| Q1 2016 | $6,629,000 | -33.9% | 16,072,000 | -4.3% | 0.20% | -33.1% |
| Q4 2015 | $10,034,000 | -17.1% | 16,788,000 | -3.8% | 0.30% | -10.3% |
| Q3 2015 | $12,101,000 | -22.8% | 17,458,000 | 0.0% | 0.34% | -14.4% |
| Q2 2015 | $15,669,000 | -15.4% | 17,458,000 | +9.0% | 0.40% | -22.3% |
| Q1 2015 | $18,523,000 | +45.9% | 16,011,000 | +26.0% | 0.51% | +72.6% |
| Q4 2014 | $12,694,000 | – | 12,710,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 9,826,000 | $2,358,000 | 1.48% |
| SILVERBACK ASSET MANAGEMENT LLC | 12,000,000 | $3,300,000 | 1.00% |
| BVF INC/IL | 10,000,000 | $2,650,000 | 0.50% |
| Partner Investment Management, L.P. | 403,000 | $111,000 | 0.16% |
| PFM Health Sciences, LP | 16,072,000 | $4,446,000 | 0.13% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 21,414,000 | $5,934,000,000 | 0.09% |
| Verition Fund Management LLC | 2,066,000 | $547,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,653,000 | $2,943,000 | 0.05% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,000,000 | $1,623,000 | 0.02% |
| Orbimed Advisors | 5,210,000 | $1,441,000 | 0.02% |